Long-term renal outcomes of patients with non-proliferative lupus nephritis

被引:4
作者
Kang, Eun-Song [1 ]
Ahn, Soo Min [1 ]
Oh, Ji Seon [2 ]
Kim, Yong-Gil [1 ]
Lee, Chang-Keun [1 ]
Bin Yoo [1 ]
Hong, Seokchan [1 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Rheumatol,Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Asan Med Ctr, Big Data Res Ctr, Dept Informat Med, Seoul, South Korea
关键词
Systemic lupus erythematosus; Lupus nephritis; Renal outcome; BIOPSY; CLASSIFICATION; TRANSFORMATION; EFFICACY; CHINESE;
D O I
10.3904/kjim.2022.339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Although non-proliferative lupus nephritis (LN) (class I, II or V) has been considered as a less severe type of LN, data on long-term renal prognosis are limited. We investigated the long-term outcomes and prognostic factors in non-proliferative LN. Methods: We retrospectively reviewed patients with systemic lupus erythematosus who were diagnosed with LN class I, II, V, or II + V by kidney biopsy from 1997 to 2021. A poor renal outcome was defined as an estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m(2). Results: We included 71 patients with non-proliferative LN (class I = 4; class II = 17; class V = 48; class II+V = 2), and the overall rate of poor renal outcomes was 29.6% (21/71). The univariate analysis indicated that older age, low eGFR at 6 or 12 months, failure to reach complete remission at 6 months, and LN chronicity score > 4 or activity score > 6 were significantly associated with poor renal outcomes. The multivariate analysis revealed that low eGFR at 6 months (HR 0.971, 95% CI 0.949- 0.991; p = 0.014) was significantly associated with poor renal outcomes. Conclusions: Poor renal outcomes occurred in approximately 30% of patients with non-proliferative LN after long-term follow-up. More active management may be needed for non-proliferative LN, especially for patients with eGFR < 60 mL/ min/1.73 m(2) at 6 months follow-up after LN diagnosis.
引用
收藏
页码:769 / +
页数:10
相关论文
共 50 条
[31]   Long-term survival of renal transplantation in patients with lupus nephritis: experience from a single university centre [J].
Martinez-Lopez, D. ;
Sanchez-Bilbao, L. ;
de Cos-Gomez, M. ;
Gonzalez-Mazon, I ;
Rodrigo-Calabia, E. ;
Ruiz-San Millan, J. C. ;
Gomez Roman, J. ;
Castanedas, S. ;
Gonzalez-Gay, M. A. ;
Hernandez, J. L. ;
Blanco, R. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) :581-588
[32]   Outcome of patients with lupus nephritis under long-term immunonephrological care [J].
Polner Kalman ;
Aranyi Jozsef ;
Braunitzer Henrik ;
Kaszas Ilona ;
Haris Agnes .
ORVOSI HETILAP, 2020, 161 (31) :1293-1301
[33]   Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis [J].
Cristiane B. Dias ;
Patrícia Malafronte ;
Jin Lee ;
Aline Resende ;
Lectícia Jorge ;
Cilene C. Pinheiro ;
Denise Malheiros ;
Viktoria Woronik .
Journal of Nephrology, 2017, 30 :87-94
[34]   Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes [J].
Yap, D. Y. H. ;
Thong, K. M. ;
Yung, S. ;
Tang, C. ;
Ma, B. M. Y. ;
Chan, T. M. .
LUPUS, 2019, 28 (12) :1460-1467
[35]   Long-term outcomes of end-stage kidney disease for patients with lupus nephritis [J].
Zhang, Lei ;
Lee, Gavin ;
Liu, Xusheng ;
Pascoe, Elaine M. ;
Badve, Sunil V. ;
Boudville, Neil C. ;
Clayton, Philip A. ;
Hawley, Carmel M. ;
Kanellis, John ;
McDonald, Stephen P. ;
Peh, Chen Au ;
Polkinghorne, Kevan R. ;
Johnson, David W. .
KIDNEY INTERNATIONAL, 2016, 89 (06) :1337-1345
[36]   Severe non-proliferative lupus nephritis with predominant sub-endothelial IgA deposits [J].
Florquin, S ;
Roos, A ;
Groothoff, JW ;
Claessen, N ;
van Gijlswijk-Janssen, DJ ;
Aten, J ;
Davin, JCMA ;
Weening, JJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) :1479-1482
[37]   Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study [J].
Boletis, John N. ;
Marinaki, Smaragde ;
Skalioti, Chryssanthe ;
Lionaki, Sofia S. ;
Iniotaki, Aliki ;
Sfikakis, Petros P. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) :2157-2160
[38]   The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis [J].
Cai, Fanghao ;
Han, Fei ;
Wang, Hongya ;
Han, Haidongqin ;
Le, Jingyun ;
Lan, Lan ;
Xu, Ying ;
Chen, Jianghua .
JOURNAL OF RHEUMATOLOGY, 2018, 45 (04) :513-520
[39]   Long-Term Mortality and Renal Outcome in a Cohort of 100 Patients With Lupus Nephritis [J].
Faurschou, Mikkel ;
Dreyer, Lene ;
Kamper, Anne-Lise ;
Starklint, Henrik ;
Jacobsen, Soren .
ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :873-880
[40]   Association of regulatory T cells with renal outcomes in patients with proliferative lupus nephritis [J].
Wang, Jingjing ;
Zhu, Mengyue ;
Jiao, Chenfeng ;
Xu, Xiaodong ;
Xu, Feng ;
Liang, Dandan ;
Liu, Zhengzhao ;
Chen, Yinghua ;
Zhang, Haitao .
LUPUS, 2023, 32 (11) :1237-1244